340B and Telehealth/HHS Waivers
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether a prescription for a patient…
Fighting to Preserve the Benefits of the 340B Program
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether a prescription for a patient…
On Thursday, July 25, 2019, the Senate Finance Committee voted to approve a wide-ranging drug pricing bill, the Prescription Drug Pricing Reduction Act (PDPRA) of 2019. The bill seeks to…
In a significant reversal of course, on Thursday, July 11, the White House announced that it was withdrawing a proposed rule by the Department of Health and Human Services’ Office…
On Thursday, May 23, Senators Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chair and ranking Democrat of the Health, Education, Labor and Pensions (“HELP”) Committee released bipartisan discussion draft…
On Thursday May 9, 2019 the House Energy and Commerce Committee, Health Subcommittee held a hearing on Lowering Prescription Drug Prices: Deconstructing the Drug Supply Chain. In the latter half…
RWC-340B will be scheduling Hill visits for members that are traveling to DC to attend SYNChronicity 2019. RWC-340B Hill visits will take place Tuesday, April 16, from about 1:00pm to…
On February 26, 2019, top executives from seven of the largest pharmaceutical companies testified before the Senate Finance Committee attempting to defend the industry’s business practices. The major focus of…
On Monday, December 10, RWC-340B members spent the day on Capitol Hill advocating for the protection of the 340B program for Ryan White grantees and sub-grantees. Participants met with their…
On October 29, 2018, RWC-340B leaders met with George Sigounas, M.S., Ph.D., the HRSA Administrator, and Beth Nelson, HHS Health Policy Advisor, to advocate to preserve and protect the 340B…
On Wednesday, October 3, the U.S. Senate approved H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (“SUPPORT”) for Patients and Communities Act, by a vote of…